The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Your definitely NOT a Sng happyinvestor
I have read all your 6 synairgen posts
And every single one has a very negative tone... below is a clip from one of them
Well, maybe not such fantastic news for this BB where, sadly, much of the focus seems to be on talking down the efficacy of vaccines and wishing that they fail.
Hopefully there will be no need and no market for SNG's therapy even IF it succeeds in trials.
Best
Happy
Thank you to Eskers for More Good news
Lots of news due soon
Below from RNS’ 20th January
“We are delighted to announce completion of recruitment into the SG016 Home trial. This is a remarkable trial evaluating a novel therapeutic delivered in the home setting to people with COVID-19 who are at risk of developing complications. We have shown that inhaled therapies can be safely delivered at home, without the need for the patients, nurses or doctors to travel. Following the promising results from the SG016 Hospital Study, we are excited to see whether we can detect important benefits from early use of inhaled interferon beta (SNG001) for COVID-19 in the home environment, in terms of resolution of symptoms, preventing hospitalisation, and reducing the burden of Long-COVID."
Toastal
https://youtu.be/iL659ziEyT8
One Billion Dollars plus....
https://www.independent.ie/business/irish/open-orphan-in-line-to-take-stake-in-1bn-flu-drug-38808471.html
When the Imutex Rns lands
https://youtu.be/7_PX1cVuaVA
The New Arden broker note does not include the Billion Dollar non core businesses
Happy Days ahead
https://youtu.be/u6zl5x8r9Bs
The Orph Train will wait for Nobody
https://youtu.be/4xa6Cr39LZU
New investors have bought into Tils only and whatever Accustem does, or doesn’t do, will have no bearing on their investment...
Only Tiziana results will influence the current share price...
Tuesday 2nd February Rns
· The CT scans of the lungs showed the improvement was approximately double that shown in patients treated with Foralumab as compared to those in the control group.
· Medical records of patients also showed a more rapid recovery in senses of smell and taste in Foralumab treated patients, as compared to those in the control group.
· Data on pharmacokinetics of nasally administered Foralumab, immunological biomarkers, stimulation of Tregs and anti-drug antibody ("ADA") is expected to be reported in a few weeks.
A Few weeks would hopefully be quite soon.
Could be very interesting quite soon
https://www.investing.com/analysis/basel-iii-could-be-golds-best-friend-200562335
I have never seen so many De-rampers out at once on a B.B. board..
They must be so desperate to try get in at a lower entrance price..
Especially one the new posters asking negative questions...who obviously don’t want to use their real account name
Ah my apologise and sorry to hear that... I hope I didn’t build any hopes up,..
But I am sure there is still lots to look forward too
Gabrielle Cerrone
It look like he is taking part, could be interesting
https://event.webinarjam.com/register/945/5vv20b3vp